Andrew M. Rauth

Departments of Medical Biophysics and Radiation Oncology, University Health Network

Affiliated withUniversity Health Network University Health Network

Research Area

Biography

Andrew M. Rauth has not added Biography.
If you are Andrew M. Rauth and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2017

Other Publications

Article	Year
Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. The Journal of pharmacy and pharmacology\| PubMed ID: 12956895	2003
A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheres. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 15491816	2004
In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations. Anti-cancer drugs\| PubMed ID: 15746579	2005
Prediction of kinetics of doxorubicin release from sulfopropyl dextran ion-exchange microspheres using artificial neural networks. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 15784330	2005
Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. Biomaterials\| PubMed ID: 15814136	2005
In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 16330194	2006
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 16547167	2006
A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharmaceutical research\| PubMed ID: 16786442	2006
Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). Pharmaceutical research\| PubMed ID: 16850265	2006
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Advanced drug delivery reviews\| PubMed ID: 17532091	2007
Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 18406489	2008
On the synergistic effect of doxorubicin and mitomycin C against breast cancer cells. Drug metabolism and drug interactions\| PubMed ID: 18447000	2007
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells. Breast cancer research and treatment\| PubMed ID: 19221875	2010
Thermally-triggered 'off-on-off' response of gadolinium-hydrogel-lipid hybrid nanoparticles defines a customizable temperature window for non-invasive magnetic resonance imaging thermometry. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 21939700	2012
Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts. Cancer letters\| PubMed ID: 22902994	2013
A novel solid lipid nanoparticle formulation for active targeting to tumor Î±(v) Î²(3) integrin receptors reveals cyclic RGD as a double-edged sword. Advanced healthcare materials\| PubMed ID: 23184795	2012
Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 23353806	2013
Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 23434679	2013
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model. Molecular pharmaceutics\| PubMed ID: 24830351	2014
A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells. Drug delivery and translational research\| PubMed ID: 25786718	2012
Evaluation of new bi-functional terpolymeric nanoparticles for simultaneous in vivo optical imaging and chemotherapy of breast cancer. Drug delivery and translational research\| PubMed ID: 25787324	2012
Optimizing the design and in vitro evaluation of bioreactive glucose oxidase-microspheres for enhanced cytotoxicity against multidrug resistant breast cancer cells. Colloids and surfaces. B, Biointerfaces\| PubMed ID: 25896537	2015
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 25908171	2015
Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 25986587	2015
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tum... Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 26772427	2016
Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia. Cancer research\| PubMed ID: 27758881	2016